Matrix metalloproteinases in ascending aortic aneurysms: bicuspid versus trileaflet aortic valves.

[1]  Timothy C Greiner,et al.  Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. , 2002, The Journal of clinical investigation.

[2]  R. Nerem,et al.  Oscillatory and steady laminar shear stress differentially affect human endothelial redox state: role of a superoxide-producing NADH oxidase. , 1998, Circulation research.

[3]  T. Sundt,et al.  Altered patterns of gene expression distinguishing ascending aortic aneurysms from abdominal aortic aneurysms: complementary DNA expression profiling in the molecular characterization of aortic disease. , 2003, The Journal of thoracic and cardiovascular surgery.

[4]  W. Roberts,et al.  The congenitally bicuspid aortic valve. A study of 85 autopsy cases. , 1970, The American journal of cardiology.

[5]  W. Pearce,et al.  Size matters: the relationship between MMP-9 expression and aortic diameter. , 1997, Circulation.

[6]  J. Scholes,et al.  Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall. , 1994, Journal of vascular surgery.

[7]  M. Leinonen,et al.  Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study. , 2001, Journal of vascular surgery.

[8]  L. Trombley,et al.  Matrix metalloproteinase activity in thoracic aortic aneurysms associated with bicuspid and tricuspid aortic valves. , 2004, The Journal of thoracic and cardiovascular surgery.

[9]  Z. Galis,et al.  Expression of Matrix Metalloproteinase-9 in Endothelial Cells Is Differentially Regulated by Shear Stress , 2003, Journal of Biological Chemistry.

[10]  M. Thompson,et al.  Increased matrix metalloproteinase 2 expression in vascular smooth muscle cells cultured from abdominal aortic aneurysms. , 2000, Journal of vascular surgery.

[11]  R. Nerem,et al.  Cyclic strain induces an oxidative stress in endothelial cells. , 1997, The American journal of physiology.

[12]  C. Ward.  Clinical significance of the bicuspid aortic valve , 2000, Heart.

[13]  Z. Galis,et al.  This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba , 2022 .

[14]  R. E. Luna,et al.  Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysms and aortic valves of patients with Marfan's syndrome. , 1998, Circulation.

[15]  D. Harrison,et al.  Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. , 1996, The Journal of clinical investigation.

[16]  W. Parks,et al.  Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. , 1996, Journal of vascular surgery.

[17]  M. Abbott.  Coarctation of the aorta of the adult type , 1928 .

[18]  G. Sicard,et al.  Indomethacin inhibits expansion of experimental aortic aneurysms via inhibition of the cox2 isoform of cyclooxygenase. , 1999, Journal of vascular surgery.

[19]  S. Shapiro,et al.  Fibrillin degradation by matrix metalloproteinases: implications for connective tissue remodelling. , 1999, The Biochemical journal.

[20]  H. Baumgartner,et al.  Mechanisms underlying aortic dilatation in congenital aortic valve malformation. , 1999, Circulation.

[21]  D. Spina,et al.  Smooth muscle cells of the media in the dilatative pathology of ascending thoracic aorta: morphology, immunoreactivity for osteopontin, matrix metalloproteinases, and their inhibitors. , 2001, Human pathology.

[22]  B. Baxter,et al.  Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[23]  B. Strauss,et al.  Vascular matrix remodeling in patients with bicuspid aortic valve malformations: implications for aortic dilatation. , 2003, The Journal of thoracic and cardiovascular surgery.

[24]  Avrum I. Gotlieb,et al.  Wall Tissue Remodeling Regulates Longitudinal Tension in Arteries , 2002, Circulation research.

[25]  H. Nagase,et al.  Identification of matrix metalloproteinases 3 (stromelysin-1) and 9 (gelatinase B) in abdominal aortic aneurysm. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[26]  S. Nakatani,et al.  Failure to Prevent Progressive Dilation of Ascending Aorta by Aortic Valve Replacement in Patients With Bicuspid Aortic Valve: Comparison With Tricuspid Aortic Valve , 2003, Circulation.

[27]  V. McKusick.  Association of congenital bicuspid aortic valve and erdheim's cystic medial necrosis. , 1972, Lancet.

[28]  Simpson Ca.  PURFICATION OF A GENE. , 1964 .

[29]  Chad Johnson,et al.  Uniaxial strain upregulates matrix-degrading enzymes produced by human vascular smooth muscle cells. , 2003, American journal of physiology. Heart and circulatory physiology.

[30]  Po-Huang Lee,et al.  Aspirin inhibits matrix metalloproteinase-2 activity, increases E-cadherin production, and inhibits in vitro invasion of tumor cells. , 2001, Biochemical and biophysical research communications.

[31]  B. Baxter,et al.  Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study. , 2002, Journal of vascular surgery.

[32]  K. Bielenberg,et al.  Ascending aortic aneurysm associated with bicuspid and tricuspid aortic valve: involvement and clinical relevance of smooth muscle cell apoptosis and expression of cell death-initiating proteins. , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[33]  M. Abbott.  Coarctation of the aorta of the adult type: II. A statistical study and historical retrospect of 200 recorded cases with autopsy, of stenosis or obliteration of the descending arch in subjects above the age of two years , 1928 .

[34]  R. Mecham,et al.  Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. , 1995, The Journal of clinical investigation.

[35]  J. Powell,et al.  Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[36]  F. Robicsek.  Aortic media in bicuspid valve disease. , 2003, The Annals of thoracic surgery.

[37]  W. Parks,et al.  Role of Matrix Metalloproteinases in Abdominal Aortic Aneurysms a , 1996, Annals of the New York Academy of Sciences.

[38]  P. Walker,et al.  Abnormal Extracellular Matrix Protein Transport Associated With Increased Apoptosis of Vascular Smooth Muscle Cells in Marfan Syndrome and Bicuspid Aortic Valve Thoracic Aortic Aneurysm , 2003, Circulation.

[39]  P. Delvenne,et al.  Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms. , 1996, Journal of vascular surgery.

[40]  P. Shah,et al.  Inflammation, metalloproteinases, and increased proteolysis: an emerging pathophysiological paradigm in aortic aneurysm. , 1997, Circulation.

[41]  H. Dietz,et al.  Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Robert W. Thompson,et al.  Abdominal aortic aneurysms: basic mechanisms and clinical implications. , 2002, Current problems in surgery.